Emparol 10 mg (Tablet)
Unit Price: ৳ 25.00 (1 x 14: ৳ 350.00)
Strip Price: ৳ 350.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Drug international ltd |
| Also available as |
Title
- Emparol 10 mg Tablet
Category
- Medicine
- Diabetes Care
- Cardiovascular Health
- Pharmacology
- Therapeutic Class
- Pregnancy & Lactation
Description
- SGLT-2 inhibitor
- Improves glycemic control
- Reduces risk of cardiovascular death
- Increases glucose excretion
- Assists weight loss
- Reduces blood pressure
- Recommended dosage of 10 mg once daily
- Can be taken with or without food
- Potential side effects: urinary tract infections, female genital mycotic infections, dehydration, hypotension, weakness, dizziness, increased thirstiness
- Storage conditions: cool & dry place below 30°C, protected from light & moisture
- Chemical structure: Molecular formula C23H27ClO7
- Common uses: control blood sugar, avoid long-term complications
- May cause dehydration and increased urination
- May cause hypoglycemia
- May cause genital fungal and/or urinary tract infections
- Requires regular blood sugar monitoring
- Pregnancy warnings
- Breast-feeding warnings
- Affects kidney function
- Affects liver function
- Usable alone or in combination with other diabetes medicines
Dosage and administration
- Recommended dose: 10 mg once daily
- Increase to 25 mg once daily in patients tolerating Empagliflozin
- Correct volume depletion before initiation
Interaction
- Co-administration with diuretics results in increased urine volume
- Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia
- SGLT2 inhibitors increase urinary glucose excretion leading to positive urine glucose tests
- Interference with 1,5-AG assay for glycemic control
Contraindications
- Contraindicated in patients with serious hypersensitivity reaction to Empagliflozin or its ingredients
- Contraindicated in severe renal impairment, end-stage renal disease, or dialysis
Side effects
- Most common: urinary tract infections, female genital mycotic infections
- Others: dehydration, hypotension, weakness, dizziness, increased thirstiness
Pregnancy and lactation
- No adequate and controlled studies in pregnant women
- Use during pregnancy if potential benefit justifies potential risk to the fetus
- Not recommended when breastfeeding
Precautions and warnings
- Assessment of renal function recommended before initiation and periodically thereafter
- Not initiated in patients with eGFR less than 45 ml/min/1.73 m2
- No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m2
Overdose effects
- Supportive measures needed in case of overdose
- Removal of Emparol by hemodialysis not studied
Chemical structure
- Molecular formula: C23H27ClO7
Common questions
- Commonly used to improve glycemic control in adults
- Unsafe to use during pregnancy
- Unsafe to use during breastfeeding
- Caution required in patients with underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
Storage conditions
- Keep in a cool & dry place below 30°C
- Protected from light & moisture
- Keep out of the reach of children